Heart Disease in Adults With Down Syndrome Between 1996 and 2016

References

1. 1.↵
   1. Bull MJ

   . Health supervision for children with Down syndrome. Pediatrics 2011;128:393–406.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Zhu JL,
   2. Hasle H,
   3. Correa A,
   4. Schendel D,
   5. Friedman JM,
   6. Olsen J,
   7. et al

   . Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med 2013;15:64–9.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Kazemi M,
   2. Salehi M,
   3. Kheirollahi M

   . Down syndrome: current status, challenges and future perspectives. Int J Mol Cell Med 2016;5:125–33.

   OpenUrl
4. 4.↵
   1. Karam SM,
   2. Riegel M,
   3. Segal SL,
   4. Félix TM,
   5. Barros AJD,
   6. Santos IS,
   7. et al

   . Genetic causes of intellectual disability in a birth cohort: a population-based study. Am J Med Genet A 2015;167:1204–14.

   OpenUrl
5. 5.↵
   Centers for Disease Control and Prevention (CDC). Data and statistics on Down Syndrome. Updated September 19, 2019. Available from: https://www.cdc.gov/ncbddd/birthdefects/downsyndrome/data.html. Accessed October 11, 2019.
6. 6.↵
   National Down Syndrome Society (NDSS). Down syndrome facts. National Down Syndrome Society. 2019. Available from: https://www.ndss.org/about-down-syndrome/down-syndrome-facts/. Accessed October 11, 2019.
7. 7.↵
   1. Englund A,
   2. Jonsson B,
   3. Zander CS,
   4. Gustafsson J,
   5. Annerén G

   . Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet A 2013;161A:642–9.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Glasson EJ,
   2. Sullivan SG,
   3. Hussain R,
   4. Petterson BA,
   5. Montgomery PD,
   6. Bittles AH

   . The changing survival profile of people with Down’s syndrome: Implications for Genetic Counselling. Clin Genet 2002;62:390–3.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Torr J,
   2. Strydom A,
   3. Patti P,
   4. Jokinen N

   . Aging in Down syndrome: morbidity and mortality. J Policy Pract Intellect Disabil 2010;7:70–81.

   OpenUrl
10. 10.↵
    1. Beange H,
    2. McElduff A,
    3. Baker W

    . Medical disorders of adults with mental retardation: a population study. Am J Ment Retard 1995;90:595–604.

    OpenUrl
11. 11.↵
    1. Alexander M,
    2. Petri H,
    3. Ding Y,
    4. Wandel C,
    5. Khwaja O,
    6. Foskett N

    . Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol 2016;58:246–54.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Bell AJ,
    2. Bhate MS

    . Prevalence of overweight and obesity in Down’s syndrome and other mentally handicapped adults living in the community. J Intell Disabil Res 2008;36:359–64.

    OpenUrl
13. 13.↵
    1. Prasher VP

    . Overweight and obesity amongst Down’s syndrome adults. J Intellect Disabil Res 1995;39:437–41.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Melville CA,
    2. Cooper SA,
    3. McGrother CW,
    4. Thorp CF,
    5. Collacott R

    . Obesity in adults with Down syndrome: a case-control study. J Intellect Disabil Res 2005;49:125–33.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Hsieh K,
    2. Hilgenkamp T,
    3. Murthy S,
    4. Heller T,
    5. Rimmer J

    . Low levels of physical activity and sedentary behavior in adults with intellectual disabilities. Int. IJERPH 2017;14:1503.

    OpenUrl
16. 16.↵
    1. Sobey CG,
    2. Judkins CP,
    3. Sundararajan V,
    4. Phan TG,
    5. Drummond GR,
    6. Srikanth VK

    . Risk of major cardiovascular events in people with Down syndrome. PLoS One 2015;10:e0137093.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Murdoch JC,
    2. Rodger JC,
    3. Rao SS,
    4. Fletcher CD,
    5. Dunnigan MG

    . Down's syndrome—An atheroma free model. Br Med J 1977;2:226–8.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Brattstrom L,
    2. England E,
    3. Brun A

    . Does Down syndrome support homocysteine theory of arteriosclerosis? Lancet 1987;329:391–2.

    OpenUrl
19. 19.↵
    1. Ylä-Herttuala S,
    2. Luoma J,
    3. Nikkari T,
    4. Kivimaki T

    . Down’s syndrome and atherosclerosis. Atherosclerosis 1989;76:269–72.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Yang Q,
    2. Rasmussen SA,
    3. Friedman JM

    . Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002;359:1019–25.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Benjamin EJ,
    2. Muntner P,
    3. Alonso A,
    4. Bittencourt MS,
    5. Callaway CW,
    6. Carson AP,
    7. et al

    . Heart disease and stroke statistics—2019 update. Circulation 2019;139:e56–e528.

    OpenUrlCrossRefPubMed
22. 22.↵
    United States Census Bureau. American fact finder ACS demographic and housing estimates: 2012–2016 American Community Survey 5-year estimates. Updated 2016. Available from: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=CF. Accessed October 9, 2019.
23. 23.↵
    1. Penney TL,
    2. Kirk SFL

    . The health at every size paradigm and obesity: missing empirical evidence may help push the reframing obesity debate forward. Am J Public Health 2015;105:e38–e42.

    OpenUrl